Search results
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Finance UK· 21 hours agoNovo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by...
Cannabis medications could be eligible for FDA approval under proposed DEA rules
The Guardian· 3 hours agoThe US Drug Enforcement Administration has proposed new rules that mean, for the first time, medications containing delta-9 THC from the cannabis plant could be eligible for approval by the ...
Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
Reuters via Yahoo Finance UK· 23 hours agoDanish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 23 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...